Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Needham

Intel Post Q2 Sales Beat, Analysts Expect Turnaround To Take Years

Shares of Intel Corp (NASDAQ:INTC) tanked in early trading on Friday, after the company on Thursday reported disappointing earnings for the second quarter.

Benzinga

Tesla Stock Faces 'Critical Milestone' Ahead: Here's What Analysts Are Flagging As Next Key Catalyst

Can Tesla Inc‘s (NASDAQ:TSLA) audacious bet on autonomy and AI outmaneuver mounting market headwinds? As analysts hold their ground despite disappointing earnings, the electric vehicle giant faces a pivotal moment that could redefine its future trajectory.

Benzinga

Amazon To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Sarepta Faces Regulatory Showdown As Analysts Cut Price Targets

On Friday, the U.S. Food and Drug Administration placed Sarepta Therapeutics Inc.’s (NASDAQ:SRPT) investigational gene therapy clinical trials for limb girdle muscular dystrophy (LGMD) on a clinical hold.

Benzinga

Nvidia Will Restart H20 Shipments to China. Should You Buy NVDA Stock Here?

Nvidia stock remains in focus on hopes that the chipmaker will soon resume business in China. Needham raised its price target on NVDA shares to $200 on Wednesday.

Barchart

Dear Netflix Stock Fans, Mark Your Calendars for July 17

The streaming giant will soon reveal its Q2 earnings, with all eyes on ad-tier growth and live content momentum.

Barchart

Dear Taiwan Semi Stock Fans, Mark Your Calendars for July 17

With earnings day nearing, all eyes are on July 17 as TSM stock fans brace to see whether Wall Street’s optimism will hold.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Shopify Shares Are Up Monday: What's Going On?

Shopify Inc. (NASDAQ:SHOP) shares are trading higher Monday after Needham Company initiated coverage on the stock with a Buy rating and a $135 price target.

Benzinga

Uber To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Netflix Stock Valuation Called 'Fair Pushback' To Buy Ratings

Netflix stock has a positive setup heading into its second-quarter earnings report, but some analysts are uneasy about its rich valuation.

Investors Business Daily

Can Circle Stock Hit $250 in 2025?

Analysts are raising eyebrows and price targets alike. With strong backing and timing, can Circle actually touch $250 soon?

Barchart

Meta Stock Gets Upgrade To Hold From One Of Last Bearish Analysts On Wall Street

Meta stock now has only one buy call on Wall Street after a longtime bear upgraded their view to neutral on Thursday.

Investors Business Daily

Can Taiwan Semiconductor Stock Hit $270 in 2025?

Will TSM stock ride the AI wave all the way to Wall Street’s fresh Street-high target?

Barchart

Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Taiwan Semiconductor Seen Rising On AI Chip Growth

Taiwan Semiconductor Manufacturing is proving to be the engine of growth for the artificial intelligence megatrend.

Benzinga

Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

International Business Times UK

Hims Stock Tumbles Down After Abrupt Exit of Novo Nordisk: Here's Everything That Went Wrong

Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated Chinese manufacturers not approved or inspected by the FDA.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl

In the battle for weight-loss supremacy, Hims & Hers Health has emerged as a dark horse candidate shaking up the market.

Barchart

Analysts: 1 Thing Apple Could Do to Make AAPL Stock a Buy Again Now

A rare downgrade from Needham urges Apple to tap into advertising as a new growth engine amid slowing earnings, rising competition, and valuation concerns.

Barchart

Apple Just Got a Rare Downgrade. Should You Ditch AAPL Stock Now?

Apple's slowing growth, rising tariffs, and AI lag could crack its trillion-dollar armor.

Investors Business Daily

Lululemon Stock Craters On Outlook Cut, Analysts Slash Targets

Lululemon stock falls after athleisure retailer cuts 2025 earnings outlook. Analysts slash price targets, but hold off from downgrades.

Barchart

Navitas Semiconductor Just Landed a Nvidia Deal. How Should You Play NVTS Stock Here?

Navitas stock skyrockets after the power semiconductor firm announced a partnership with Nvidia. Needham analysts warn the NVTS rally may have gone a bit too far.

Investors Business Daily

Shoe Stocks Rally On China Deal. On Holding, Birkenstock To Report.

Shoe stocks are rallying after U.S. and China announce trade deal. Crocs, Skechers among winners. On Holding, Birkenstock to report.

Investors Business Daily

Why IBD Stock Of The Day Penumbra, Up 27% This Year, Is Making A Comeback

Penumbra is Friday's IBD Stock Of The Day. After pulling back following a post-earnings breakout, Penumbra stock is eyeing two new entries.

1 2 3 4 5

People

Margaret Kaczor Andrew

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations